Article by Elizabeth Chiu, CBC News
Health Canada says it will begin random testing of medical marijuana products to check for the presence of banned pesticides after product recalls affecting nearly 25,000 customers led to reports of illnesses and the possibility of a class action lawsuit.
Late last year, licensed medical marijuana producers Organigram of Moncton, N.B., and Toronto-based Mettrum voluntarily recalled products due to the presence of low levels of the prohibited chemicals myclobutanil, bifenazate and pyrethrins, all of which are prohibited in tobacco and marijuana.
In January, nearly all of Organigram’s products sold in 2016 were pulled in a higher-level voluntary recall.
On Health Canada’s Jan. 9 recall notice, the department said it had “not received any adverse reaction reports for products sold by Organigram Inc.”
However, CBC News has confirmed that a Halifax woman, Dawn Rae Downton, who had received one of the Health Canada notices, had earlier complained to Health Canada about non-stop nausea and vomiting.
‘I am living proof’ of adverse effects
Downton, 60, had a medical marijuana licence for her inflammatory arthritis. She said she’s upset she received nothing more than a form letter in November.
“I am living proof there have been very adverse effects. I lost eight months of my life,” she said. “I’m living proof that Health Canada is not protecting medical marijuana patients.”